NCT02239952 2020-10-08
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)
Amsterdam UMC, location VUmc
Phase NA Unknown
Clinical Trials
13 trialsNCT00272350 2019-12-05
ZD6474 to Treat Advanced Brain Cancer in Patients
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00441142 2019-03-05
Zactima
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT00937417 2017-04-24
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
SWOG Cancer Research Network
Phase 1 Withdrawn
NCT00995007 2016-03-29
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01941849 2015-12-21
VIBRaNT
University College, London
Phase 1 Withdrawn
NCT00821080 2015-05-01
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Massachusetts General Hospital
Phase 1 Completed
NCT00996723 2015-04-06
Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00822887 2013-06-26
IRUSZACT0073
University of Colorado, Denver
Phase 1 Completed
NCT00613223 2013-02-20
Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Duke University
Phase 1 Completed
NCT00613054 2012-12-05
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
Duke University
Phase 1 Completed
NCT00472017 2012-10-15
Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00533169 2011-12-15
ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
M.D. Anderson Cancer Center
Phase 1 Terminated